Title: Neurological Biomarker Market Forecast to 2027
1Neurological Biomarker Market
Neurological Biomarker Market Forecast to 2027 -
COVID-19 Impact and Global Analysis by Product
(Proteomics Biomarker, Genomics Biomarker,
Metabolomics Biomarker, Imaging Biomarker,
Others) Application (Alzheimer's Disease,
Parkinson's Disease, Schizophrenia, Huntington's
Disease, Spinal Muscular Atrophy, Others) End
User (Pharmaceutical and Biotechnology Companies,
Clinical Diagnostics, Research Organizations)
and Geography
2Current and future Market Scenario
Neurological Biomarker Market
- According to our new market research study on
Neurological Biomarker Market to 2028 Global
Analysis and Forecast by Type, Treatment, and
End User, the market is expected to reach US
14,454.7 million by 2027 from US 5,501.8 million
in 2019. The market is estimated to grow at a
CAGR of 13.0 from 2020 to 2027. - The genomic biomarkers segment held the largest
share of the global neurological biomarker
market, based on product, in 2019, and it is
expected to register the highest CAGR during the
forecast period. This segment is likely to
witness a lucrative growth owing to increasing
consumer awarenessabout the benefits of genetic
medicines as well as technological advancements
in the field of neurological biomarkers.
3Market Segments
Neurological Biomarker Market
By Product Proteomics Biomarker Genomics
Biomarker Metabolomics Biomarker Imaging
Biomarker Others
By End User Pharmaceutical and Biotechnology
Companies Clinical Diagnostics Research
Organizations
By Application Alzheimer's Disease Parkinson's
Disease Schizophrenia Huntington's Disease Spinal
Muscular Atrophy Others
4Leading Players
Neurological Biomarker Market
Company Profiles in Neurological Biomarker
Market are Thermo Fisher Scientific
Inc. Abbott Myriad Genetics, Inc. Bio-Rad
Laboratories Inc. QIAGEN Banyan Biomarkers,
Inc Immunarray Pvt. Ltd. Quest Diagnostics
Incorporated Perkin Elmer, Inc. MERCK KGaA
5 Neurological Biomarker Market
Access Full Research Report at
https//www.theinsightpartners.com/reports/neurolo
gical-biomarker-market
Thank You!